Related by context. All words. (Click for frequent words.) 76 Initiates Enrollment 75 Completes Patient Enrollment 74 Initiates Phase III 73 Commences Phase 73 Pivotal Phase III 73 Initiates Phase II 73 Presents Positive 73 Meets Primary Endpoint 72 Initiates Clinical 72 Phase III Clinical Trial 71 Hsp# Inhibitor 71 Tezampanel 71 Phase 2b Clinical Trial 71 Completes Enrollment 71 Therapeutic Competitors companiesandmarkets.com adEgemonye 71 Enrolls First 71 initiated Phase Ib 71 Receives Orphan Drug Designation 71 Initiate Phase 71 acetonide FA 70 Phase IIb Trial 70 molecular imaging radiopharmaceutical 70 PROVENGE ® 70 Therapeutic Competitors Companies 70 delivers fluocinolone acetonide FA 70 Files IND 70 Xcytrin R 70 Phase IIb Clinical Trial 70 Presents Positive Preclinical 70 Begins Dosing 70 Clinical Trial Results 70 Successfully Completes Phase 70 IND Filing 70 drug pipeline TAFA# 69 SPL# Gel vaginal microbicide 69 Submits Response 69 Pivotal Trial 69 Completes Patient Enrolment 69 Combination REOLYSIN R 69 Receives Approvable Letter 69 mGluR5 negative 69 Achieves Primary Endpoint 69 huC# DM4 69 Personalized Immunotherapy 69 Presents Preclinical 69 Vascular Disrupting Agent 69 Granted Orphan Drug 69 Topline Results 69 NDA Submission 69 JAK2 Inhibitor 69 Presents Preclinical Data 69 TRANSDUR ® 69 Patient Enrollment 68 immunosuppressive compound 68 Receives Milestone Payment 68 Initiates Phase 68 Initiates Clinical Trial 68 First Patient Enrolled 68 highly purified pasteurized 68 Submits NDA 68 Civacir 68 Receives Fast Track 68 Severe Sepsis 68 Elagolix 68 GTC recombinant form 68 TRACON Pharmaceuticals 68 MKC# MKC# PP 68 Matrix Phase 2b 68 Pivotal Clinical Trial 68 Randomized Phase 68 MIVI III 68 Demonstrates Significant 68 FOLOTYN ® 68 CRMD# 68 FDA APPROVES 68 markets HP Acthar 68 Nasdaq PGNX today 68 Receives Orphan Drug 68 Nasdaq HALO 68 candidates Azedra 68 Nasdaq VRTX today 68 dependent kinase inhibitor 68 PDX pralatrexate 68 Single Dose 67 Regeneron Pharma 67 NASDAQ ISTA 67 SinuNase TM 67 novel MetAP 2 67 Phase III Pivotal 67 virus HCV protease inhibitor 67 Phase III Trial 67 Study Evaluating 67 Hedgehog Pathway Inhibitor 67 Therapeutic Competitors 67 RANK Ligand inhibitor 67 Gel repository corticotropin injection 67 SinuNase ™ 67 Inc Therapeutic Competitors 67 Begins Clinical Trial 67 brand ciclesonide HFA 67 targeted radiotherapeutic 67 Phase 2a Clinical Trial 67 mertansine 67 JAK Inhibitor 67 TRANSDUR ™ 67 Files Investigational 67 vapreotide acetate 67 Commence Phase 67 First Patient Dosed 67 Randomized Double Blind 67 Investigational Compound 67 Pivotal Study 67 non nucleoside inhibitor 67 arsenic trioxide injection 67 Aflibercept 67 PROVENGE sipuleucel T 67 NYSE Amex PTN 67 Patient Enrolment 67 Submits Biologics License Application 67 OMRIX Biopharmaceuticals Inc. 67 Qutenza TM 67 NASDAQ CLDX 67 PRAECIS PHARMACEUTICALS INCORPORATED 67 Earns Milestone Payment 67 Demonstrates Positive 67 NYSE Amex PBTH 67 investigational pan BCR 66 Pivotal Phase 66 Dyloject TM 66 NasdaqGM NTEC today 66 ocular formulation 66 Myocet 66 Announces Tentative Approval 66 Nicotine Conjugate Vaccine 66 candidate XP# 66 please visit http:/www.vandapharma.com 66 TM Aganocide 66 ORAL Sync 66 BUPHENYL R 66 ZEVALIN ® 66 ARCALYST R 66 Treatment Experienced 66 evaluating tivozanib 66 Novel Oral 66 telomerase therapeutic 66 including eniluracil ADH 66 oral prodrug 66 successfully commercialize Iluvien 66 phase IIb clinical 66 methylnaltrexone bromide 66 Cleviprex TM clevidipine 66 liver resection surgeries 66 lexidronam injection 66 Milestone Payment 66 Vascular Wrap TM 66 OTCBB CVBT 66 Eluting Coronary Stent System 66 trastuzumab Herceptin R 66 Phase 1b Clinical Trial 66 Crofelemer budesonide foam 66 NUEDEXTA ™ 66 oxybutynin ATD TM 66 ALN HPN 66 Abstract Accepted 66 Oral NKTR 66 MAGE A3 ASCI 66 Mg Usa 66 Aloxi ® 66 NOVAVAX 66 GTC recombinant human 66 Nasdaq DVAX 66 TO AVOID PREGNANCY WHILE 66 BARACLUDE R 66 PRN FDA Approves 66 orally administered inhibitor 66 Present Preclinical Data 66 Oral Calcitonin 66 Metastatic Melanoma 66 unique alkylating agent 66 GetGoal Phase III 66 severe hypercholesterolemia 66 Announces Poster Presentations 66 ferumoxytol Injection 66 Nasdaq IMGN 66 subsidiaries visit http:/www.apricusbio.com 66 Phase #b/#a clinical 66 Solazed TM 66 4SC AG ISIN DE# 66 Ceflatonin R 66 IMPACS R 66 Efficacy Results 66 Glufosfamide 66 GATTEX TM 66 oral picoplatin 66 candidate AQ4N 66 AAG geldanamycin analog 66 candidate deforolimus 66 R roscovitine CDK cyclin 66 Reveals Positive 66 EndoBarrier ™ 66 Nasdaq OPTR 66 KRYSTEXXA TM pegloticase 66 Bepreve TM 66 leading oral taxane 66 OTCBB HXBM developer 66 Initiates Clinical Trials 66 Pafuramidine 66 Cypher Sirolimus 66 topical gel formulation 66 acyclovir Lauriad R 65 Initiate Clinical Trial 65 Cardioxyl Pharmaceuticals 65 Staphylococcus aureus Immune Globulin 65 Luveris R Ovidrel R 65 Kuvan R 65 Ganite ® 65 Oracea ® 65 Empatic ™ 65 Mylan Receives Approval 65 Omacetaxine 65 Preclinical Data 65 NASDAQ EMIS 65 FUSILEV ® 65 anticancer compound 65 Receives CE Marking 65 Announcement acc 65 Nasdaq EPCT 65 commercializing Loramyc ® 65 BRIM2 65 SUCCEED trial 65 Diabetic Macular Edema 65 CD# CEA 65 BYETTA ® 65 Locteron ® 65 Aganocide 65 NASDAQ ADLR 65 Vidaza R 65 intranasal formulation 65 Multiple Ascending Dose 65 DURECT proprietary 65 TAXUS Element Paclitaxel Eluting 65 motexafin gadolinium Injection 65 Phase 2b Trial 65 rALLy clinical trial 65 docetaxel Taxotere R 65 TKB# 65 investigational antiplatelet agent 65 LymphoStat B TM 65 Tesetaxel 65 Nasdaq XTLB 65 Telik logo TELINTRA 65 midstage clinical 65 Targanta Therapeutics Corporation 65 phase III isavuconazole 65 APEX PD 65 oral ridaforolimus 65 DepoCyt ® Abelcet ® 65 documented candidiasis 65 Plicera 65 Xeloda ® 65 Panzem R NCD 65 Tibotec Therapeutics division 65 COLAZAL R 65 Brentuximab Vedotin SGN 65 candidates Azedra TM 65 PROSTASCINT R 65 Receives Positive Opinion 65 Pulmonary Arterial Hypertension 65 Gentamicin Surgical Implant 65 Dose Ranging Study 65 oral proteasome inhibitor 65 Aurexis 65 Iloperidone 65 lenalidomide Revlimid R 65 NASDAQ BDSI 65 Reports Preclinical Data 65 OTCBB PYTO 65 OMNARIS HFA 65 Chronic Hepatitis C 65 ENDEAVOR III 65 NASDAQ ARRY 65 non nucleoside HCV 65 Prolongs Survival 65 liposomal formulation 65 First Patient Treated 65 Æterna Zentaris Inc. 65 Vaccine Adjuvant 65 Taglich Brothers Initiates Coverage 65 novel VDA molecule 65 Xanafide 65 Announce License Agreement 65 ABLYNX 65 Dose Escalation 65 Testosterone MDTS R 65 albiglutide 65 vinorelbine tartrate 65 MEK Inhibitor 65 CYT# potent vascular disrupting 65 label Lipofen R 65 Nasdaq TARG 65 Cloretazine ® 65 Phase 2b Study 65 PANVAC VF 65 SPRYCEL ® 65 Transcept Pharmaceuticals 65 trastuzumab DM1 T DM1 65 Silodosin 65 refractory chronic lymphocytic 65 Inc. OTCBB ALRX 65 Risperidone Oral Solution 65 Randomized Double blind 65 Randomized Phase II 65 Gets FDA Clearance 65 ASE SVA 65 Cynapsus Therapeutics Inc. 65 allosteric modulator NAM 65 Onalta 65 metaglidasen 65 2 inhibitor CYT# 65 Intravenous Human 65 Harbor BioSciences 65 Traficet EN 65 IPSEN 65 By JENNIFER LEARN 65 Testosterone Gel 65 histone deacetylase HDAC inhibitor 65 PHX# 65 Wafer polifeprosan 65 Sapacitabine 65 TM Drug Eluting 65 BEMA Granisetron 65 Ecallantide 65 initiated Phase 1b 65 ALN PCS 65 BCG refractory carcinoma 64 PROMUS R 64 TAXUS Element Stent System 64 Phase Ib II 64 NASDAQ CGEN announced 64 XL# anticancer compounds 64 investigational humanized monoclonal antibody 64 By JAMAAL ABDUL 64 NicVAX TM 64 delta opioid receptor 64 Nasdaq ADLR 64 miconazole MBT 64 NASDAQ PGNX 64 lead molecular radiotherapeutic 64 MKC# MT 64 catheter occlusion 64 HCV protease inhibitor 64 DosePro TM 64 MOVIPREP R 64 Bradmer Pharmaceuticals 64 Inhalation Aerosol 64 pralatrexate injection folate analogue 64 NASDAQ AVNR 64 R MSCRAMM 64 EDEMA3 64 Expanded Indication 64 Anturol TM 64 compound INCB# 64 developing Zerenex ferric 64 Allovectin 7 r 64 PDUFA Date 64 Phase Ib study 64 lucinactant 64 ELADUR ™ 64 Clinical Trial Evaluating 64 Spectrum Pharmaceuticals Announces 64 PERSEUS 64 novel histone deacetylase 64 iloprost Inhalation Solution 64 IMPDH inhibitor 64 NASDAQ CRXL 64 Vitrasert R 64 REPRONEX R menotropins 64 Nasdaq NPSP announced 64 VentiRx Pharmaceuticals 64 Flamel Technologies Announces 64 developing Bicifadine serotonin 64 NASDAQ IDRA 64 ABL inhibitor 64 Iluvien ® 64 topically applied SEPA 64 Novolimus 64 SUPPRELIN R LA 64 oral dual endothelin 64 EXPLORE Xa 64 sodium Injection 64 Evoclin R 64 Inc. Nasdaq IMGN 64 Phase 2a Trial 64 TELINTRA R 64 Application MAA 64 apricitabine ATC 64 Nasdaq VNDA 64 Emollient Foam 64 reduce serum phosphate 64 Mg Uk 64 PROMUS Element Stent 64 Submits IND 64 JOULFERON 64 Locteron exclusively 64 Amigal TM 64 OvaRex ® MAb 64 StaphVAX R 64 Receives NASDAQ 64 NASDAQ AEZS TSX AEZ 64 Catalyst Biosciences 64 Testosterone MDTS ® 64 Gonal f R 64 Phase III Clinical Trials 64 XL# XL# 64 Soriatane R 64 TSX VENTURE IGX OTCBB 64 Sanvar R 64 OvaRex R 64 MIND CTI LTD 64 Targeted Chemotherapy 64 Dr. Cauwenbergh 64 NASDAQ DYAX 64 bevirimat Study 64 Anti CD# Antibody 64 Nasdaq IDIX 64 sapropterin dihydrochloride Tablets 64 NOTE POSIDUR ™ 64 Antitumor Activity 64 XL# XL# XL# 64 Luveniq 64 product platforms AZX# 64 Pyridorin TM 64 dextofisopam 64 generation Hsp# inhibitor 64 Nasdaq CLDX 64 Immunomedics Announces 64 Ovitrelle R Serostim 64 oritavancin semi 64 BRIM3 64 Nasdaq AUXL 64 Pegloticase 64 BiovaxID TM 64 telomerase inhibitor drug 64 FOLFOX6 chemotherapy regimen 64 UPLYSO 64 delivery polymer matrix 64 Regenerative Cells 64 Inc. NASDAQ AEZS 64 VEGFR2 inhibitor 64 Valera Pharmaceuticals 64 Therapeutic Competitors Report 64 R rilonacept Injection 64 IG HCR ;) CO 64 PI3K/Akt pathway inhibitor 64 ASX PGL 64 rasagiline tablets 64 PSDV 64 PNP inhibitor 64 CAPHOSOL R 64 Fast Track Status 64 Alnylam Nasdaq ALNY 64 Drug Candidate 64 OMRIX Biopharmaceuticals 64 AMEX DDD 64 Ridaforolimus 64 Ohr Pharmaceutical Inc. 64 FDA Approvable Letter 64 Announces FDA Clearance 64 Sunesis Pharma 64 phase IIb trial 64 mesylate tablets 64 Drug Eluting Stent System 64 IRX 2 64 Pruvel TM 64 OTCBB VCRT 64 Release Capsules 64 LibiGel transdermal testosterone gel 64 interferon gamma 1b 64 Polymer Microspheres 64 Pooled Analysis 64 Dalbavancin 64 Initiated Phase 64 INSPIRE Trial Phase III 64 achieved CCyR 64 ENZON 64 FACTIVE R gemifloxacin 64 Idera Pharmaceuticals 63 hypoxia selective 63 Nitazoxanide 63 5 HT3 antagonist 63 RECOTHROM R 63 PEGINTRON TM 63 NASDAQ AVEO 63 Alvine Pharmaceuticals 63 Completes Dosing 63 TBC# 63 Besivance 63 NASDAQ CLSN 63 Phase 1a clinical 63 hyaluronidase enzyme 63 lintuzumab SGN 63 Nasdaq BCRX 63 TNF Tumor Necrosis Factor 63 overactive bladder AA# 63 CCR5 mAb 63 Varespladib 63 R# #mg BID 63 VIVITROL ® 63 Genasense ® oblimersen 63 candidate NGX 63 Gamunex C 63 BioSante Pharmaceuticals Announces 63 #/#/# SciClone Pharmaceuticals 63 NASDAQ LGND 63 multicenter Phase III 63 aripiprazole Abilify 63 HGS ETR2 63 oncolytic virus therapies 63 equine osteoarthritis marketed 63 Immunotherapeutic 63 Second Pivotal Phase 63 pan histone deacetylase 63 CoFactor 63 Tibotec BVBA 63 Tesamorelin 63 rilonacept Injection 63 GTC NASDAQ GTCB 63 BLP# Liposome Vaccine 63 ANIK 63 Hematide ™ 63 markets COLAZAL 63 agonistic human 63 investigational oral inhibitor 63 Generx TM 63 TRO# 63 randomized controlled multicenter 63 plus Copegus R 63 Randomized Double Blind Placebo 63 Nasdaq CYCC 63 RECOTHROM ® 63 personalized cellular immunotherapy 63 Japanese Encephalitis Vaccine 63 MorphoSys AG FSE MOR 63 evaluating mipomersen 63 Elotuzumab 63 Nasdaq RIGL 63 oral salmon calcitonin 63 Initiates Dosing 63 NASDAQ REGN 63 Nasdaq PGNX 63 ZOMIG R 63 AMEX RGN 63 docetaxel Taxotere ® 63 HCV RNA polymerase 63 erlotinib Tarceva R 63 ongoing Phase 1b 63 IL# PE#QQR 63 white petrolatum Ointment 63 Initiates Phase 2b 63 Phase III ADT 63 Nasdaq NBIX 63 Azedra TM 63 oral dihydropyrimidine dehydrogenase DPD 63 Lupus Drug 63 TASKi2 63 Nasdaq NYMX 63 Oracea TM 63 OMAPRO ™ 63 Nasdaq PARD 63 Romiplostim 63 LE SN# 63 Extends Collaboration 63 Receive Milestone Payment 63 PROMUS TM 63 Complicated Skin 63 Oral Fingolimod 63 FDA Approvals 63 Inc. Nasdaq AVRX 63 product Fentanyl TAIFUN 63 OTC BB PVCT 63 Nasdaq RGEN 63 MT# MEDI 63 Aldara ® 63 Taro Receives 63 ™ Paclitaxel Eluting 63 LymphoStat B belimumab 63 Zemiva TM 63 GALNS 63 registrational Phase 63 2 methoxyestradiol 63 Augment TM 63 AMEX ONI 63 forodesine 63 PEG SN# 63 Milestone Payment From 63 HCl PEPCID ® famotidine 63 Testim R 63 VivaGel ™ 63 mitogen activated ERK kinase 63 XP# XP# 63 platinum chemotherapeutic 63 Through Glycoscience R 63 PHASE III 63 Gastrointestinal Liner 63 SAR# [002] 63 OTCQX QRXPY 63 topical non steroidal 63 cyclobenzaprine hydrochloride extended 63 Transdermal Patch 63 Solution XOPENEX HFA 63 OTC BB EMIS 63 Pirfenidone 63 octreotide implant 63 IV APAP 63 Inc. NASDAQ SCLN 63 Emezine 63 Paris IPN Euronext 63 IMA# 63 XOPENEX R 63 NASDAQ IDEV 63 Cethromycin 63 candidate MyVax 63 LEVADEX TM 63 PGL# 63 Enzon Pharmaceuticals Inc 63 Inhalation Powder 63 NASDAQ AKRX 63 Locteron combines 63 candidate CRLX# 63 FDA Accepts 63 Phase Ib IIa 63 OTCBB DORB 63 Double Blind Placebo 63 sapropterin dihydrochloride 63 Pruvel ™ 63 Liberte TM 63 evaluating picoplatin 63 ENLIGHT 63 Commences Phase III 63 Indaflex TM 63 novel topoisomerase 63 intravenous acetaminophen 63 dihydrochloride Tablets 63 R bendamustine hydrochloride 63 ABILIFY ® 63 HGS ETR1 mapatumumab 63 TLK# 63 Bayer HealthCare Onyx Pharmaceuticals 63 Panzem R 63 Febuxostat 63 non peptidic protease 63 BayStreet.ca Research Alert 63 histamine dihydrochloride 63 cetuximab Erbitux R 63 hyperphenylalaninemia HPA due 63 Nasdaq RDEA 63 Dabigatran etexilate 63 OTCBB TDLP 63 ADP receptor antagonist 63 Zenpep 63 selective A2A adenosine receptor 63 please visit www.advaxis.com 63 Exherin TM 63 Phase III Trials 63 Initiate Phase III 63 Phase 2a Study 63 TM Everolimus Eluting 63 investigational pharmacologically unique 63 lexidronam injection PROSTASCINT 63 MEND CABG 63 Methylnaltrexone 63 balsalazide disodium Capsules 63 Announces Dosing 63 Cardium Therapeutics TM 63 XPEL Announces 63 phase IIb study 63 candidate brentuximab vedotin 63 OctoPlus licensed 63 personalized dendritic 63 drug eluting coronary stent 63 Phase IIIb clinical 63 tiapamil 63 NasdaqGM SPPI 63 Acute Ischemic Stroke 63 Kinase Inhibitor 63 OMP designation 63 IDEV Technologies 63 CUSTOM III 63 Phenoptin 63 Roche OTC RHHBY 63 Cetrorelix 63 ALN TTR 63 NASDAQ SNTA 63 Systemic Delivery 63 Medidur TM FA 63 ExTRACT TIMI 63 Zenvia ™ 63 Kahalalide F 63 PERSEUS clinical program 63 Crucell NV NYSE Euronext 63 rxRNA 63 R#/MEM # 63 Phase #b/#a trial 63 pan HDAC inhibitor 63 PEGylated anti 62 TSX VENTURE GAP 62 combines bupropion 62 REGENERX BIOPHARMACEUTICALS INC. 62 Atripla combines 62 Million Milestone Payment 62 Keryx Biopharma 62 doxercalciferol 62 NASDAQ ACOR 62 Fludara ® 62 Nuvelo Announces 62 Anturol ® 62 NVA# 62 Anidulafungin 62 Safinamide 62 R lenalidomide 62 palonosetron hydrochloride injection 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 Nasdaq CGEN 62 Agile Therapeutics 62 AMMONUL R sodium phenylacetate 62 HuMax TAC 62 PrevOnco 62 polysaccharide polymer 62 initiate Phase 1b 62 recurrent metastatic ovarian cancer 62 Anika Therapeutics 62 proprietary intranasal insulin 62 Phase IIB 62 LSE SHP.L 62 Nasdaq ISTA 62 Multicenter Phase 62 Nasdaq THLD 62 Prodarsan R 62 NASDAQ KERX 62 Submits Supplemental 62 Neulasta R 62 GVAX ® 62 phase IIa clinical 62 Arno Therapeutics 62 ACTIQ ® 62 ® tiagabine hydrochloride 62 platform HDL Mimetic 62 DUROS 62 Zorbtive TM 62 MGd 62 ELADUR TM 62 II Clinical Trial 62 Nasdaq VRTX 62 Inc. Nasdaq CYCC 62 Onco TCS 62 ZALBIN 62 Biomerix Corporation 62 abacavir sulfate lamivudine 62 induced macular edema 62 INFeD R 62 Rhucin ® recombinant 62 NASDAQ FLML 62 Sumatriptan Succinate 62 CLARITY study 62 XTNT 62 Novel Antibiotic 62 Randomized Clinical Trials 62 transthyretin mediated amyloidosis ATTR 62 Medidur ™ FA 62 CINQUIL 62 Increlex TM 62 Eurand Pharmaceuticals 62 cUTI 62 Sanofi aventis EURONEXT SAN 62 Adenosine Therapeutics 62 ThermoDox ® clinical 62 diaper dermatitis complicated 62 BENLYSTA ® 62 Iluvien TM 62 TapImmune Inc. 62 small molecule Hedgehog 62 XIAFLEX ® 62 novel DACH platinum 62 Genasense R oblimersen 62 Sirion Therapeutics 62 CysDisplay R 62 ATRA IV 62 Cyclacel Pharmaceuticals 62 Announces Initiation 62 DIRECT Trial 62 orBec ® oral beclomethasone 62 NYSE Amex RNN 62 Sagent Pharmaceuticals Announces 62 PRNewswire FirstCall Nastech Pharmaceutical 62 CancerVax Corporation 62 herpetic keratitis 62 Begins Shipment 62 Nps Pharmaceuticals Incorporated 62 Biopharmaceuticals AG 62 Inc. Nasdaq ATHX 62 KRN# 62 Trubion Pharma 62 Chemophase 62 Eniluracil 62 Nexavar sorafenib tablets 62 PROCTOCORT R 62 Indevus Pharma 62 BUPHENYL 62 elotuzumab 62 Apricus Biosciences 62 ENDEAVOR IV 62 Vion Pharmaceuticals 62 Aztreonam lysine 62 Orapred ODT 62 Euronext Paris Code Isin 62 Alocrest 62 adecatumumab MT# 62 THAT ARE DIFFICULT TO 62 HYVISC ® treatment 62 Parathyroid Hormone 62 Entereg R 62 Nasdaq CADX 62 Corlux 62 Somatuline Depot 62 OMS#HP 62 Æterna Zentaris 62 Serdaxin ® 62 Oscient Pharmaceuticals Corporation 62 Alfacell proprietary ribonuclease 62 OTCBB QTXB 62 R sorafenib tablets 62 EURONEXT SAN 62 bevacizumab Avastin R 62 PENTASA 62 evaluating satraplatin 62 BTRX 62 alvespimycin 62 CyDex Pharmaceuticals 62 T Pred 62 MAA submission 62 Investorideas.com newswire BioSante PharmaceuticalLarne Holyhead 62 Pegylated Liposomal Doxorubicin 62 Phase Ib clinical 62 RGB # 62 Inc. OTCBB MBCI 62 PLK1 SNALP 62 candidate iSONEP TM 62 Collaborators Present 62 MKC# 62 PDE4 inhibitor 62 Durezol TM 62 CYP#A# CYP#D# 62 novel emulsion formulation 62 Intermezzo ® zolpidem tartrate 62 plasma kallikrein inhibitor 62 LEUKINE 62 selective androgen receptor modulator 62 sapropterin dihydrochloride Phase 62 candidate TNFerade biologic 62 Enters Into Collaboration 62 dasatinib Sprycel ® 62 MBRX 62 KNS # 62 Jumps Higher 62 SYCREST 62 Agonist MABA program 62 therefore therapeutically equivalent 62 QUADRAMET R 62 Pralatrexate 62 Investigational Drug 62 Advancing Drugs 62 NASDAQ OPTR 62 OTCBB FCSC 62 Nasdaq KERX 62 Rigel R# 62 Placebo Controlled Trial 62 rALLy 62 Daclizumab 62 Amrubicin 62 Randomized Clinical Trial 62 HuMax EGFr 62 MyVax R 62 monoclonal antibody IgG1 Mab 62 relapsed refractory multiple myeloma 62 therapeutically inactive prodrug 62 Sufentanil 62 ZOLINZA 62 REVIVE Diabetes 62 Biliary System 62 CTAP# Capsules 62 YONDELIS 62 Generic Version 62 interferon beta 1a infertility 62 GEN PROBE 62 multicenter Phase 62 DRRX 62 Sulonex TM 62 selective estrogen receptor modulator 62 mGluR2 positive 62 BrachySil TM 62 Omigard TM 62 HCV NS5B polymerase 62 peripherally acting 62 Curis NASDAQ CRIS 62 OTCBB UGNE http:/www.unigene.com 62 ALTROPANE R 62 Bicifadine 62 Friedreich Ataxia FRDA 62 XOMA XOMA 62 secretory phospholipase A2 62 Unit Dose Budesonide 62 website www.celsion.com 62 Spiegelmer ® 62 ularitide 62 vitreoretinal disorders 62 include Phenoptin TM 62 Sunesis Pharmaceuticals 62 Clinical Study Shows 62 NASDAQ TARG 62 cytomegalovirus immune globulin 62 Angiox ® 62 Surgical Mesh 62 coronary stent merged 62 Valtropin 62 fluocinolone acetonide 62 CONBRIZA 62 Receives Complete Response 62 Oral Insulin 62 NASDAQ PPDI 62 VISICOL R 62 pentadentate logo R 62 Kaydon Corporation Announces 62 Androxal TM 62 PREOS R 62 Levoleucovorin 62 NAVISTAR R 62 adenosine injection 62 Files Shelf Registration Statement 62 NASDAQ ONXX 62 Icatibant 62 Inc. Nasdaq SEPR 62 NASDAQ NPSP 62 Inc. NASDAQ BPAX 62 RGDX 62 Protease Inhibitor 62 Opterone R 62 TRX1 62 Recombinant Human 62 Veronate 62 Nasdaq SPNC 62 inhaled formulation 62 Aeroquin 62 Proquin XR 62 Thrombin topical Recombinant 62 NASDAQ SCMP 62 antibiotic candidate Ramoplanin 62 t2cure GmbH 62 Nasdaq ACAD 62 NASDAQ VNDA 62 Phase 2a clinical trials 62 Ophena TM 62 Cariprazine 62 PRT# 62 Zemiva ™ 62 www.vivus.com 62 Study Showed 62 2A receptor agonist 62 hydrochloride tablets 62 receptor tyrosine kinase inhibitor 62 NASDAQ AEZS 62 Well Tolerated 62 triciribine phosphate monohydrate 62 OLpur TM H2H 62 Marketing Authorisation Application 62 Axcan Pharma Holding BV 62 Plaque Psoriasis 62 budesonide foam 62 NASDAQ RNAI 62 Phase 1b clinical trials 62 diagnostic radiopharmaceutical 62 sapacitabine CYC# 62 Thiarabine 62 Nasdaq GNTA 62 InNexus Biotechnology 62 oral nucleoside analogue 62 Shows Promising 62 www.adeonapharma.com 62 fosbretabulin 62 Proellex TM 62 Civacir TM Hepatitis C 62 OncoGel 62 ISENTRESS raltegravir 62 Nasdaq IDRA today 62 CCX# B 62 bone marrow reticulin deposition 62 Anti Tumor 62 palifosfamide Zymafos TM 62 Phase Ib clinical trials 62 PSMA ADC